Occupational Skin-Disease Reports in 706 Nurses
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: What can this study tell workers, families and occupational-health teams—and what would go beyond the evidence? This review keeps every number attached to its population, denominator, comparator and timepoint.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 706 nurses from different hospital departments. |
| Design | Questionnaire-based occupational study with information collected about disinfectant use. |
| Comparator | Reported disease and exposure patterns across departments and workplace factors; no external non-nurse control group was described. |
| Timepoint | Single study assessment; the abstract does not specify a recall window or prospective follow-up. |
| Key result | Occupational skin disease was reported in 47.3%; allergic contact dermatitis in 28.5% and irritant contact dermatitis in 8.4%. Aldehydes, hydrogen peroxide, latex gloves and long hours were reported as risk factors. |
| Funding/conflict context | No grant or conflict-of-interest statement appears in the PubMed record retrieved for this review. |
What was actually measured?
Occupational skin disease was reported in 47.3%; allergic contact dermatitis in 28.5% and irritant contact dermatitis in 8.4%. Aldehydes, hydrogen peroxide, latex gloves and long hours were reported as risk factors.
The study points to disinfectant, glove and workload variables that are more actionable than the nursing title alone. The abstract uses diagnostic language, but the described methods center on a questionnaire.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
No external control, unclear clinical confirmation, unspecified response rate and recall window, and cross-sectional exposure reporting prevent causal interpretation or a current prevalence estimate.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 14587537
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Four Dermatitis Assessments Across 751 Construction Workers
- Validating Functional-Disability Scores in 422 Dermatitis Patients
- Two-to-Five-Year Follow-Up of 19 Workers Meeting Mathias Criteria
- Dermatitis and Acrylate Allergy in 174 Dental Personnel
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.